Quality of well-being scale

Last updated

The Quality of Well-Being Scale (QWB) is a general health quality of life questionnaire which measures overall status and well-being over the previous three days in four areas: physical activities, social activities, mobility, and symptom/problem complexes. [1]

Contents

It consists of 71 items and takes 20 minutes to complete. [2] There are two different versions of the QWB; the original was designed to be administered by an interviewer, and the second development (the QWB-SA) was designed to be self-administered. [3]

The four domain scores of the questionnaire are combined into a total score that ranges from 0 to 1.0, with 1.0 representing optimum function and 0 representing death. [4]

Development

The QWB was originally called the Health Status Index, then the Index of Well-Being, and then eventually became the Quality of Well-Being Scale. [2] It has undergone several modifications since its development.

The process of administering the QWB can be described in three stages. They are the assessment of functional status, scaling the responses and indicating prognosis.

Assessment of functional status involves a structured interview which records the symptoms and problems experienced over the last eight days. It is used to classify the patient’s level of functioning. The interview takes about seven minutes or longer, according to the patient’s level of health. Questions in the interview covered three criteria of functioning: physical activity, social activity and mobility and confinement. The interview also records the presence of symptoms or problem complexes, which are problems that were experienced on the previous day, but were not being experienced at the present time. [5]

The responses from the interview were then scaled. Preference weights were given for each function level by 867 raters. The preference weights indicated the social judgement of the importance of each function level. A score is generated, which is known as W. W can then be adjusted to reflect the prognosis of a given medical condition. [2]

International use

Since the development of the Quality of Well-Being Scale and the consequent Quality of Well-Being Scale-Self Administered, the questionnaire has been utilized in numerous studies worldwide. Due to the general nature of the questionnaire, it has proven useful in a variety of different formats and contexts.

One way in which the QWB and the QWB-SA has been utilized is that it has been a comparator used to validate other measures, or a starting point for creating subscales of the questionnaire. An example of this is a subscale developed for use with the QWB-SA that assesses mental health, [6] a comparator study seeking to investigate the Health and Activity Limitation Index [7] and a study seeking to validate a new questionnaire called the Assessment of Quality of Life (AQoL)-8D. [8]

The QWB and the QWB-SA have also been validated or assessed for suitability in various cultures and countries. The QWB has been assessed for use in Trinidad and Tobago [9] and the QWB-SA has been validated for German patients with prostate disease, [10] as well as Chinese patients with epilepsy. [11] When the QWB-SA's Spanish version was assessed for its applicability in Spain, researchers identified some sociocultural issues in the translation. For example, some translated terms and usage applied US-specific concepts and regional lexical choices and cannot be successfully implemented in Spain without adaptation. [12]

See also

Self-perceived quality-of-life scale

Related Research Articles

Psychological testing refers to the administration of psychological tests. Psychological tests are administered or scored by trained evaluators. A person's responses are evaluated according to carefully prescribed guidelines. Scores are thought to reflect individual or group differences in the construct the test purports to measure. The science behind psychological testing is psychometrics.

A pain scale measures a patient's pain intensity or other features. Pain scales are a common communication tool in medical contexts, and are used in a variety of medical settings. Pain scales are a necessity to assist with better assessment of pain and patient screening. Pain measurements help determine the severity, type, and duration of the pain, and are used to make an accurate diagnosis, determine a treatment plan, and evaluate the effectiveness of treatment. Accurately measuring pain is a necessity in medical settings, especially if the pain measurement is going to be used as a screening tool, either for potential diseases or medical problems, or as a type of triage to determine urgency of one patient over another. Pain scales are based on trust, cartoons (behavioral), or imaginary data, and are available for neonates, infants, children, adolescents, adults, seniors, and persons whose communication is impaired. Pain assessments are often regarded as "the 5th vital sign".

The Liebowitz Social Anxiety Scale (LSAS) is a short questionnaire developed in 1987 by Michael Liebowitz, a psychiatrist and researcher at Columbia University and the New York State Psychiatric Institute. Its purpose is to assess the range of social interaction and performance situations feared by a patient in order to assist in the diagnosis of social anxiety disorder. It is commonly used to study outcomes in clinical trials and, more recently, to evaluate the effectiveness of cognitive-behavioral treatments. The scale features 24 items, which are divided into two subscales. 13 questions relate to performance anxiety and 11 concern social situations. The LSAS was originally conceptualized as a clinician-administered rating scale, but has since been validated as a self-report scale.

The BASDAI or Bath Ankylosing Spondylitis Disease Activity Index is a validated diagnostic test which allows a physician, usually a rheumatologist, to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of Ankylosing spondylitis (AS). The BASDAI is one of a group of classification criteria for spondyloarthropathies.

A patient-reported outcome (PRO) is a health outcome directly reported by the patient who experienced it. It stands in contrast to an outcome reported by someone else, such as a physician-reported outcome, a nurse-reported outcome, and so on. PRO methods, such as questionnaires, are used in clinical trials or other clinical settings, to help better understand a treatment's efficacy or effectiveness. The use of digitized PROs, or electronic patient-reported outcomes (ePROs), is on the rise in today's health research setting.

The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints. The WOMAC has also been used to assess back pain, rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, and fibromyalgia. It can be self-administered and was developed at Western Ontario and McMaster Universities in 1982.

<span class="mw-page-title-main">Quality of life (healthcare)</span> Notion in healthcare

In general, quality of life is the perceived quality of an individual's daily life, that is, an assessment of their well-being or lack thereof. This includes all emotional, social and physical aspects of the individual's life. In health care, health-related quality of life (HRQoL) is an assessment of how the individual's well-being may be affected over time by a disease, disability or disorder.

The Patient Health Questionnaire (PHQ) is a multiple-choice self-report inventory that is used as a screening and diagnostic tool for mental health disorders of depression, anxiety, alcohol, eating, and somatoform disorders. It is the self-report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD), a diagnostic tool developed in the mid-1990s by Pfizer Inc. The length of the original assessment limited its feasibility; consequently, a shorter version, consisting of 11 multi-part questions - the Patient Health Questionnaire was developed and validated.

The Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire is a patient-reported outcome (PRO) measure which assesses the quality of life of patients with ankylosing spondylitis. The ASQoL is based on the needs-based quality of life model. It is a self-administered questionnaire which contains 18 items and takes up to four minutes to complete.

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is a disease specific patient-reported outcome measure which assesses quality of life of patients with pulmonary hypertension (PH). It was the first pulmonary hypertension specific questionnaire for assessing patient reported symptoms, quality of life and functioning.

The Psoriatic Arthritis Quality of Life (PsAQoL) measure is a disease specific patient-reported outcome measure which measures the effect that psoriatic arthritis has on a patient’s quality of life.

The Quality of Life In Depression Scale (QLDS), originally proposed by Sonja Hunt and Stephen McKenna, is a disease specific patient-reported outcome which assesses the impact that depression has on a patient's quality of life. It is the most commonly used measure of quality of life in clinical trials and studies of depression. The QLDS was developed as a measure to be used in future clinical trials of anti-depressant therapy.

The Unidimensional Fatigue Impact Scale (U-FIS) is a disease-specific patient-reported outcome measure which measures the impact of multiple sclerosis related fatigue. It is a 22-item unidimensional scale which is based on needs-based quality of life theory.

The Somatic Symptom Scale - 8 (SSS-8) is a brief self-report questionnaire used to assess somatic symptom burden. It measures the perceived burden of common somatic symptoms. These symptoms were originally chosen to reflect common symptoms in primary care but they are relevant for a large number of diseases and mental disorders. The SSS-8 is a brief version of the popular Patient Health Questionnaire - 15 (PHQ-15).

EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys. EQ-5D assesses health status in terms of five dimensions of health and is considered a ‘generic’ questionnaire because these dimensions are not specific to any one patient group or health condition. EQ-5D can also be referred to as a patient-reported outcome (PRO) measure, because patients can complete the questionnaire themselves to provide information about their current health status and how this changes over time. ‘EQ-5D’ is not an abbreviation and is the correct term to use when referring to the instrument in general.

The Dimensional Obsessive-Compulsive Scale (DOCS) is a 20-item self-report instrument that assesses the severity of Obsessive-Compulsive Disorder (OCD) symptoms along four empirically supported theme-based dimensions: (a) contamination, (b) responsibility for harm and mistakes, (c) incompleteness/symmetry, and (d) unacceptable (taboo) thoughts. The scale was developed in 2010 by a team of experts on OCD led by Jonathan Abramowitz, PhD to improve upon existing OCD measures and advance the assessment and understanding of OCD. The DOCS contains four subscales that have been shown to have good reliability, validity, diagnostic sensitivity, and sensitivity to treatment effects in a variety of settings cross-culturally and in different languages. As such, the DOCS meets the needs of clinicians and researchers who wish to measure current OCD symptoms or assess changes in symptoms over time.

Functional Assessment of Cancer Therapy - General (FACT-G) is a patient-reported outcome measure used to assess health-related quality of life in patients undergoing cancer therapy. The FACT-G is the original questionnaire that led to the development of the larger Functional Assessment of Chronic Illness Therapy (FACIT) collection of quality of life instruments. The survey assesses the impacts of cancer therapy in four domains: physical, social/family, emotional, and functional. The FACT-G is also offered with additional questions measuring cancer-specific factors that may affect quality of life, leading to the creation of the Functional Assessment of Cancer Therapy - Head and Neck (FACT-H&N), the Functional Assessment of Cancer Therapy - Lung (FACT-L), and 18 others.

The Attribution Questionnaire (AQ) is a 27-item self-report assessment tool designed to measure public stigma towards people with mental illnesses. It assesses emotional reaction and discriminatory responses based on answers to a hypothetical vignette about a man with schizophrenia named Harry. There are several different versions of the vignette that test multiple forms of attribution. Responses assessing stigma towards Harry are in the form of 27 items rated on a Likert scale ranging from 1 (not at all) to 9 (very much). There are 9 subscales within the AQ that breakdown the responses one could have towards a person with mental illness into different categories. The AQ was created in 2003 by Dr. Patrick Corrigan and colleagues and has since been revised into smaller tests because of the complexity and hypothetical that did not capture children and adolescent's stigmas well. The later scales are the Attribution Questionnaire-9 (AQ-9), the revised Attribution Questionnaire (r-AQ), and the children's Attribution Questionnaire (AQ-8-C).

References

  1. ↑ "Rehab Measures: Quality of Well Being and Self-Administered version". RehabMeasures.org. Rehabilitation Institute of Chicago. Retrieved 11 December 2013.
  2. 1 2 3 McDowell, Ian (2006). MEASURING HEALTH: A Guide to Rating Scales and Questionnaires (PDF). New York: Oxford University Press. pp. 675–683. ISBN   978-0195165678.
  3. ↑ "Quality of Well Being". SCIREproject.com. Monkey Hill Health Communications. Retrieved 11 December 2013.
  4. ↑ "Health-Related Quality of Life Measures". HealthMeasurement.org. The Health Measurement Research Group. Retrieved 11 December 2013.
  5. ↑ Busija, L; Pausenberger, E; Haines, TP; Haymes, S; Buchbinder, R; Osborne, RH (Nov 2011). "Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL)" (PDF). Arthritis Care & Research. 63 (Suppl 11): S383–412. doi: 10.1002/acr.20541 . PMID   22588759.
  6. ↑ Sarkin, AJ; Groessl, EJ; Carlson, JA; Tally, SR; Kaplan, RM; Sieber, WJ; Ganiats, TG (Sep 2013). "Development and validation of a mental health subscale from the Quality of Well-Being Self-Administered". Quality of Life Research. 22 (7): 1685–96. doi:10.1007/s11136-012-0296-2. PMC   4819419 . PMID   23104088.
  7. ↑ Boslaugh, SE; Andresen, EM; Recktenwald, A; Gillespie, K (Jan 2009). "Evidence for potential bias in the Health and Activity Limitation Index as a health preference measure for persons with disabilities". Disability and Health Journal. 2 (1): 20–6. doi:10.1016/j.dhjo.2008.07.004. PMID   21122739.
  8. ↑ Richardson, J; Iezzi, A; Khan, MA; Maxwell, A (Nov 23, 2013). "Validity and Reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility Instrument". The Patient. 7 (1): 85–96. doi:10.1007/s40271-013-0036-x. PMC   3929769 . PMID   24271592.
  9. ↑ Hector RD, Sr; Anderson, JP; Paul, RC; Weiss, RE; Hays, RD; Kaplan, RM (Jun 2010). "Health state preferences are equivalent in the United States and Trinidad and Tobago". Quality of Life Research. 19 (5): 729–38. doi:10.1007/s11136-010-9630-8. PMC   2874060 . PMID   20237958.
  10. ↑ Frosch, D; Porzsolt, F; Heicappell, R; Kleinschmidt, K; Schatz, M; Weinknecht, S; Kaplan, RM (2001). "Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease". Quality of Life Research. 10 (2): 165–73. doi:10.1023/a:1016771205405. PMID   11642687. S2CID   11838636.
  11. ↑ Gao, L; Xia, L; Pan, SQ; Xiong, T; Li, SC (Sep 2013). "Validation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy". Epilepsia. 54 (9): 1647–57. doi:10.1111/epi.12324. PMID   23875999.
  12. ↑ Congost-Maestre, Nereida (2020-04-30). Sha, Mandy (ed.). Sociocultural issues in adapting Spanish health survey translation: The case of the QWB-SA (Chapter 10) in The Essential Role of Language in Survey Research. RTI Press. pp. 203–220. doi: 10.3768/rtipress.bk.0023.2004 . ISBN   978-1-934831-24-3.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.